Skip to main content
SpringerLink
Log in

Warum wirkt Botulinumtoxin bei chronischer Migräne?

  • aktuell
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

„Wir haben gelernt, Botulinumtoxin wirkt auf die Acetylcholinausschüttung der motorischen Nervenfasern. Warum soll es dann bei chronischer Migräne wirken?“

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Blaschek A et al. Cephalalgia 1012, 32: 241 – 9

  2. Calandre EP et al. Eur J Neurol 2006, 13: 244 – 9

    Article  CAS  PubMed  Google Scholar 

  3. Gazerani P et al. Pain 2006; 122: 315 – 25

    Article  CAS  PubMed  Google Scholar 

  4. Restani L et al. PLoS Pathog 2012; 8: e1003087

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Matthias Hermann

Authors
  1. Matthias Hermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

„Warum wirkt Botulinumtoxin bei der chronischen Migräne?“, Andreas Straube, München, DPG/AKBtx Kongress in Berlin, 16. – 18.4.2015

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hermann, M. Warum wirkt Botulinumtoxin bei chronischer Migräne?. InFo Neurologie 17, 56–57 (2015). https://doi.org/10.1007/s15005-015-1334-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-015-1334-8

Search

Navigation